James W Young

This inventor holds 50 USPTO granted patents, plus 3 CIPO patents, primarily in Pharmaceutical Compositions. Top assignees: Sepracor, Inc., Georgetown University, The Mclean Hospital Corporation. Active years: 1979-2004.

USPTO Granted Patents = 50

% Patents Active = 88.0

CIPO Patents = 3 (Patent Applications = 15)

Average Co-Inventor Count = 1.5

ph-index = 17

Forward Citations = 648(Granted Patents)

Forward Citations (Not Self Cited) = 617(Dec 10, 2025)

Location History:

Grand Prairie, TX (US) (1983 - 1988)
Still River, MA (US) (1992 - 2000)
Palo Alto, CA (US) (1979 - 2004)

Company Filing History:

Georgetown University

patents

1 out of 125

The Mclean Hospital Corporation

patents

4. 1 out of 2,202

The United States of America as Represented by the Secretary of

patents

5. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1979-2004

Loading Chart...

Areas of Expertise:

Hypertension

Depression

Infections

Optically Pure

Amlodipine

Bupropion

Lomefloxacin

Bronchodilation

Asthma

Gastro-Esophageal Reflux

Cognitive Disorders

Analgesic

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6753338 - Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine (2004-06-22),

2. 6534508 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2003-03-18),

3. 6451860 - Methods for treating depression and other disorders using optically pure (−)-bupropion (2002-09-17),

4. 6451826 - Optically pure (−) amlodipine compositions (2002-09-17),

5. 6448275 - Methods for treating hypertension and angina using salts of optically pure (−) amplodipine (2002-09-10),

6. 6436936 - Methods and compositions for treating disorders, using optically pure (+) zopiclone (2002-08-20),

7. 6369113 - Method for treating depression using optically pure (−)-bupropion (2002-04-09),

8. 6337339 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2002-01-08),

9. 6291490 - Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine (2001-09-18),

10. 6277887 - Methods for treating Parkinson's disease using optically pure (−)-bupropion (2001-08-21),

11. 6274595 - Compositions for treating infection using optically pure (S)-lomefloxacin (2001-08-14),

12. 6110973 - Methods for treating obesity and weight gain using optically pure (2000-08-29),

13. 6083993 - Method for treating bronchospasm using optically pure R(-) albuterol (2000-07-04),

14. 6075024 - Methods for treating infection using optically pure (S)-lomefloxacin (2000-06-13),

15. 6069154 - Methods for treating gastro-esophageal reflux disease using optically (2000-05-30),

Title: The Innovative Journey of James W Young

Introduction: James W Young, a distinguished inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: James W Young holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, James W Young has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, James W Young has collaborated with top scientists, engineers, and researchers to bring his visionary ideas to life. His collaborative efforts have resulted in the successful implementation of numerous groundbreaking projects.

Conclusion: James W Young's relentless passion for innovation and his commitment to pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs.